OGDEN CHRISTOPHER (See Remarks) sold 4.1% of their position (8.55K shares) of CYTOMX THERAPEUTICS, INC. on the open market
Open‑market sale worth $5.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/20/2025ACC: 0001610717-25-000085
Officer· See Remarks
Since Feb 2022
-8.55K
Net shares
Net seller
$5.1K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
8.55K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−8.55K
Price / share
$0.60
Trade value
$5.12K
% of position
4.1%
3/18/2025
209.58K→201.03K
Total
Net shares
−8.55K
Net value
-$5.12K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/18/2025 | S · Sale | −8.55K | $0.60 | $5.12K | 4.1% | 209.58K | 201.03K |
| Total | −8.55K | -$5.12K | ||||||
Derivative Transactions0
No derivative transactions reported